Based on the key indicators related to Chemours' liquidity, profitability, solvency, and operating efficiency, Chemours Co may be sliding down financialy. It has an above-average probability of going through some form of financial hardship next quarter. At present, Chemours' Total Current Liabilities is projected to increase significantly based on the last few years of reporting. The current year's Total Stockholder Equity is expected to grow to about 1.1 B, whereas Common Stock Shares Outstanding is forecasted to decline to about 138.6 M. Key indicators impacting Chemours' financial strength include:
Investors should never underestimate Chemours' ability to pay suppliers on time, ensure interest payments are not accumulating, and correctly time where and how to reinvest extra cash. Individual investors need to monitor Chemours' cash flow, debt, and profitability to make informed and accurate decisions about investing in Chemours Co.
Cash And Equivalents
1.3 Billion
Chemours
Select Account or Indicator
Market Cap
Enterprise Value
Price To Sales Ratio
Dividend Yield
Ptb Ratio
Days Sales Outstanding
Book Value Per Share
Free Cash Flow Yield
Operating Cash Flow Per Share
Stock Based Compensation To Revenue
Capex To Depreciation
Pb Ratio
Ev To Sales
Free Cash Flow Per Share
Roic
Inventory Turnover
Net Income Per Share
Days Of Inventory On Hand
Payables Turnover
Sales General And Administrative To Revenue
Research And Ddevelopement To Revenue
Capex To Revenue
Cash Per Share
Pocfratio
Interest Coverage
Payout Ratio
Capex To Operating Cash Flow
Pfcf Ratio
Days Payables Outstanding
Income Quality
Roe
Ev To Operating Cash Flow
Pe Ratio
Return On Tangible Assets
Ev To Free Cash Flow
Earnings Yield
Intangibles To Total Assets
Net Debt To E B I T D A
Current Ratio
Tangible Book Value Per Share
Receivables Turnover
Graham Number
Shareholders Equity Per Share
Debt To Equity
Capex Per Share
Graham Net Net
Revenue Per Share
Interest Debt Per Share
Debt To Assets
Enterprise Value Over E B I T D A
Short Term Coverage Ratios
Price Earnings Ratio
Operating Cycle
Price Book Value Ratio
Price Earnings To Growth Ratio
Days Of Payables Outstanding
Dividend Payout Ratio
Price To Operating Cash Flows Ratio
Price To Free Cash Flows Ratio
Pretax Profit Margin
Ebt Per Ebit
Operating Profit Margin
Effective Tax Rate
Company Equity Multiplier
Long Term Debt To Capitalization
Total Debt To Capitalization
Return On Capital Employed
Debt Equity Ratio
Ebit Per Revenue
Quick Ratio
Dividend Paid And Capex Coverage Ratio
Net Income Per E B T
Cash Ratio
Cash Conversion Cycle
Operating Cash Flow Sales Ratio
Days Of Inventory Outstanding
Days Of Sales Outstanding
Free Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage Ratios
Price To Book Ratio
Fixed Asset Turnover
Capital Expenditure Coverage Ratio
Price Cash Flow Ratio
Enterprise Value Multiple
Debt Ratio
Cash Flow To Debt Ratio
Price Sales Ratio
Return On Assets
Asset Turnover
Net Profit Margin
Gross Profit Margin
Price Fair Value
Return On Equity
Change To Inventory
Stock Based Compensation
Free Cash Flow
Change In Working Capital
Other Cashflows From Financing Activities
Depreciation
Other Non Cash Items
Capital Expenditures
Total Cash From Operating Activities
Change To Account Receivables
Net Income
Total Cash From Financing Activities
Other Cashflows From Investing Activities
Sale Purchase Of Stock
Investments
Change In Cash
Net Borrowings
Total Cashflows From Investing Activities
Dividends Paid
Change To Netincome
Change To Liabilities
Change Receivables
Exchange Rate Changes
Cash And Cash Equivalents Changes
End Period Cash Flow
Begin Period Cash Flow
Cash Flows Other Operating
Common Stock Shares Outstanding
Total Assets
Other Current Liab
Total Current Liabilities
Total Stockholder Equity
Other Liab
Property Plant And Equipment Net
Current Deferred Revenue
Accounts Payable
Non Current Assets Total
Non Currrent Assets Other
Other Assets
Long Term Debt
Net Receivables
Good Will
Liabilities And Stockholders Equity
Non Current Liabilities Total
Inventory
Other Current Assets
Other Stockholder Equity
Total Liab
Property Plant And Equipment Gross
Total Current Assets
Accumulated Other Comprehensive Income
Short Term Debt
Intangible Assets
Common Stock
Property Plant Equipment
Net Tangible Assets
Retained Earnings
Cash
Deferred Long Term Liab
Long Term Investments
Short Long Term Debt
Short Long Term Debt Total
Noncontrolling Interest In Consolidated Entity
Net Debt
Cash And Short Term Investments
Retained Earnings Total Equity
Long Term Debt Total
Capital Surpluse
Additional Paid In Capital
Treasury Stock
Non Current Liabilities Other
Accumulated Depreciation
Cash And Equivalents
Net Invested Capital
Net Working Capital
Capital Lease Obligations
Depreciation And Amortization
Interest Expense
Selling General Administrative
Total Revenue
Gross Profit
Other Operating Expenses
Operating Income
Ebit
Research Development
Ebitda
Cost Of Revenue
Total Operating Expenses
Income Before Tax
Total Other Income Expense Net
Income Tax Expense
Net Income Applicable To Common Shares
Minority Interest
Net Income From Continuing Ops
Non Recurring
Tax Provision
Interest Income
Non Operating Income Net Other
Net Interest Income
Reconciled Depreciation
Probability Of Bankruptcy
Understanding current and past Chemours Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Chemours' financial statements are interrelated, with each one affecting the others. For example, an increase in Chemours' assets may result in an increase in income on the income statement.
Please note, the presentation of Chemours' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Chemours' management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Chemours' management manipulating its earnings.
Chemours Stock Summary
Chemours competes with International Flavors, Air Products, PPG Industries, Linde Plc, and LyondellBasell Industries. The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. The Chemours Company was founded in 2014 and is headquartered in Wilmington, Delaware. Chemours operates under Specialty Chemicals classification in the United States and is traded on New York Stock Exchange. It employs 6400 people.
Comparative valuation techniques use various fundamental indicators to help in determining Chemours's current stock value. Our valuation model uses many indicators to compare Chemours value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Chemours competition to find correlations between indicators driving Chemours's intrinsic value. More Info.
Chemours Co is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers reporting about 0.27 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Chemours Co is roughly 3.67 . At present, Chemours' Return On Equity is projected to slightly decrease based on the last few years of reporting. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Chemours' earnings, one of the primary drivers of an investment's value.
Chemours Systematic Risk
Chemours' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Chemours volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was fourteen with a total number of output elements of fourty-seven. The Beta measures systematic risk based on how returns on Chemours correlated with the market. If Beta is less than 0 Chemours generally moves in the opposite direction as compared to the market. If Chemours Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Chemours is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Chemours is generally in the same direction as the market. If Beta > 1 Chemours moves generally in the same direction as, but more than the movement of the benchmark.
Chemours Thematic Clasifications
Chemours Co is part of several thematic ideas from Plastics to Chemicals Makers. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Get More Thematic Ideas
Today, most investors in Chemours Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Chemours' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Chemours growth as a starting point in their analysis.
Price Earnings To Growth Ratio
(0.2)
At present, Chemours' Price Earnings To Growth Ratio is projected to increase slightly based on the last few years of reporting.
Chemours February 25, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Chemours help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Chemours Co. We use our internally-developed statistical techniques to arrive at the intrinsic value of Chemours Co based on widely used predictive technical indicators. In general, we focus on analyzing Chemours Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Chemours's daily price indicators and compare them against related drivers.
When running Chemours' price analysis, check to measure Chemours' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chemours is operating at the current time. Most of Chemours' value examination focuses on studying past and present price action to predict the probability of Chemours' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Chemours' price. Additionally, you may evaluate how the addition of Chemours to your portfolios can decrease your overall portfolio volatility.